Gold Spot / U.S. Dollar
Long
Updated

5164 - a key price zone for buyers.

193
🔺Related Information: (XAU/USD)

Washington and Tehran are poised to hold another round of negotiations in Geneva on Thursday, underscoring the view within Donald Trump’s administration that Iran has tabled credible and substantive proposals. These reportedly include measures to scale back its holdings of highly enriched uranium, a step intended to demonstrate that Tehran is not pursuing nuclear weapons capabilities and to keep diplomatic channels firmly open.
Iran’s Foreign Minister Abbas Araghchi struck a cautiously optimistic tone, noting that the probability of achieving a negotiated outcome remains meaningful. From a market perspective, however, sentiment remains finely balanced. While continued dialogue may temper immediate geopolitical risk, any deterioration in talks or renewed escalation in US–Iran relations would likely reignite risk aversion, reinforcing flows into traditional safe-haven assets such as Gold over the near term.

🔜🔜🔜🔜🔜🔜🔜🔜🔜🔜

📌 Chart analysis:

🔗 Short-term timeframes: M15, M45, H1
Short-term timeframes are showing a bullish consensus, after the H1 chart broke through the key resistance level of 5164.
A break above 5191 is needed for greater buying pressure.
Trading volume is currently above the EMA lines.

🔗 Medium-term timeframes: H2, H4
Accumulation on the H4 timeframe after filling the liquidity gap, creating a long-term breakout (BOS).

Key zones:
🔗 Supply zone (resistance): 5,246
🔗 Demand zone (support): 5,164 ; 5097
🔗 Three EMA moving averages; technical indicators: stochastic, volume

🔜🔜🔜🔜🔜🔜🔜🔜🔜🔜

✏️ Personal opinion:

The upward trend remains stable across multiple timeframes; as long as it stays above 5110, the uptrend will continue.The market is bullish due to tariff policies, but gold is rising amid investor anxiety.

📥 Follow us for the most accurate gold price trends.
Trade active
Gold swept liquidity around the 5164 support level and rebounded. The uptrend remains intact.

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.